Big Gain For MacroGenics, Inc.
Fri, Feb 17, 2023 at 07:18 PM
MacroGenics, Inc. (MGNX:NASDAQ) soared at $6.61, representing a gain of 25.7%. On Fri, Feb 17, 2023, MGNX:NASDAQ touched a New 2-Week High of $6.61. The stock appeared on our News Catalysts scanner on Tue, Feb 14, 2023 at 01:25 PM in the 'BIOTECH' category. From Fri, Feb 03, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Nov 14, 2022 at $7.57 with a volume of 1M+.
About MacroGenics, Inc. (MGNX:NASDAQ)
Macrogenics Inc is a clinical-stage biopharmaceutical company. It focusses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases.
Top 10 Gainers:
- iBio, Inc. (IBIO:NYSEMKT), 97.28%
- OKYO Pharma Limited (OKYO:NASDAQ), 58.47%
- Movella Holdings Inc Com (MVLA:NASDAQ), 46.56%
- Apexigen Inc Com (APGN:NASDAQ), 44.21%
- AMC Networks Inc. (AMCX:NASDAQ), 32.34%
- Eos Energy Enterprises Inc. (EOSE:NASDAQ), 27.45%
- MacroGenics, Inc. (MGNX:NASDAQ), 25.67%
- United States Cellular Corporation (USM:NYSE), 24.52%
- Telephone and Data Systems, Inc. (TDS:NYSE), 23.09%
- Meihua International Medical Technologies Co. Ltd. (MHUA:NASDAQ), 22.46%